Antibody could lead to HIV vaccine


Recommended Posts

Antibody could lead to HIV vaccine

Scientists discover how substance fights off AIDS virus

WASHINGTON, June 26 ? Researchers said Thursday they have figured out how a rare antibody sees past the disguises of the AIDS virus ? a finding that may lead to a vaccine that will finally work against the killer microbe.

THE ANTIBODY, taken from a unusual patient whose body can resist the virus, recognizes and attacks the human immunodeficiency virus, unlike most of the body?s defense. ?Nothing like this has ever been seen before,? Ian Wilson of The Scripps Research Institute in La Jolla, Calif., who led the research, said in a statement. AIDS has killed 25 million people around the world and is projected to kill 80 million by 2010. The only real hope of fighting the incurable virus is a vaccine, but efforts so far have flopped although dozens of vaccines are being tested.

Antibodies are an important arm of the body?s defenses against germs. They are usually able to recognize an invader by structures on its surface, called antigens, and can either call in help, or neutralize it themselves by pasting themselves against it. Most vaccines in use today stimulate the production of neutralizing antibodies. The human body makes plenty of antibodies against HIV, but the virus disguises itself with human sugars. One antibody seems to be able to see past this ruse. Called 2G12, it was found by Austrian researchers a decade ago in a patient who seemed to resist acquired immune deficiency syndrome ? the condition caused as HIV destroys the immune system over time.

ANTIBODY?S SPECIAL STRUCTURE

Writing in the journal Science, Wilson and colleagues said they had figured out how 2G12 does it. It recognizes that while HIV is covered up with human sugars, they are not arranged in a human-like way. The antibody does this with a special structure of its own, which Wilson and colleagues, including a team at Oxford University in Britain, have crystallized and imaged. ?The Fab (antigen recognition) arms are interlocked,? said Scripps researcher Dennis Burton, who worked on the study. ?That is a unique arrangement, and it is good for recognizing a cluster of shapes like sugars on a virus.?

Now what needs to be done is to use the structure of the antibody as a template to design an antigen to stimulate the production of 2G12 or another antibody that will neutralize HIV, the researchers said. The approach might also work for making vaccines against other germs, said Wilson. ?Can we now use this to engineer antibodies with higher affinity against other antigens or clusters of antigens?? he ask

Source: MSNBC

Link to comment
https://www.neowin.net/forum/topic/88327-antibody-could-lead-to-hiv-vaccine/
Share on other sites

Cool. Very cool. Looks like I'll have to buy Journal of Science this month.

I hope that patents do not get applied to this. There's millions of people whos lives could be saved or improved as a result of this. I for one am not going to let a patent pass on this w/o putting up a serious fight.

Now thats some really good news there shockz.If they can find an antibody that can fight aids maybe just maybe a cure for cancer might not be to far off,Ive lost family and friends to cancer :( so news like this can only bring hope.Thanks for the info.

Edited by Danimal
Can you imagine that test group?

"We'd like to find out if you're immune to HIV, would you please accept this injection so we can rule you out?"

That's being silly.

They're not going to inject people w/ it. They would proably first test the DNA in individuals and see if they carry the gene responsible for making that particular antibody. After, they'll collect a sample of blood, put in the AIDS virus and see how well the antibodies fight it off. Then if all is sucessfull they'll start w/ clinical trials in a few years.

Now thats some really good news there shockz.If they can find an antibody that can fight aids maybe just maybe a cure for cancer might not be to far off,Ive lost family and friends to cancer :( so news like this can only bring hope.Thanks for the info.

someone actually posted a news article here recently that said that scientists created some sort of injection, and mice with brain cancer were completely cured. 50% of the mice who didn't get the injection died, and the other 50% showed no sign of cancer at all.

they're hoping it'll translate over into humans

someone actually posted a news article here recently that said that scientists created some sort of injection, and mice with brain cancer were completely cured. 50% of the mice who didn't get the injection died, and the other 50% showed no sign of cancer at all.

they're hoping it'll translate over into humans

Yeah I heard that too on the news on TV, and they interviewed a guy about it. Although I didn't read the review posted on this website, the news definately sounded promicing. This could be just what we are searching for.......unfortunately costs for the drug are/will be extremely high, according to the piece I saw.

that's good news, but i wish they worked quick to find cure for cancer, which in my opinion is a lot more imprtant that aids, because cancer victims aren't responsible for surferring, while AIDs victims though, not all of the times, are responsible for catching the virus. My point being, with good care, AIDS can and should be prevented, however there has been no totally proven way to stop cancer.

Props to the scientists in England for finding this! This could open a huge gateway to disease fighting, and possibly lead a to a cure for cancer quicker.

That's something that annoys me greatly about medicine. The costs of treatment. I always liken it to this little scenario...

"doctor...I'm dying.... please, can you treat me?"

"Sure thing sonny, but first, show me the color of your money!"

That is what it comes down to. Sure, we can cure you but it's gonna cost ya. So sad... :no:

Yeah, unfortuantely its not the doctors that set the prices - its the drug manufacturers themselves. And they are not making drugs and medicine for the perpose of curing people - they treat it as a business and are purely there to make money.

I heard somwhere (sorry, no source I'll try and find one....) that a lot of todays drugs that the public have to pay for could be made and sold at a much cheaper price. The only reason they charge so much is because of business - they want to make as much monet as possible, and people can't say 'no' beacuse they, in most cases, really need the drugs in order to live a normal life. That to me is sad, and really needs to be sorted out - people should not pay copious amounts of money just to save their own lives (or at least live at a higher standard of life), when they could be be paying the minimum - just the making costs, not the extra which goes straight into manufacturer's back pockets.

--EDIT--

Here are some (loose) links to what I was trying to describe. They do not explain fully what I was reffering to above, but they give you some idea that price manipulation does happen:

http://www.cbgnetwork.org/home/Newsletter_...kcb__29___.html

http://desmoinesregister.com/opinion/stori...5/20275512.html

http://www.prescription-drugs-lawsuits.com/

Edited by farsightxc2
i didnt know it'd be expensive, that sucks, but it figures. but really, if i had cancer and it meant paying 10,000 dollars or dying, who do i write the check to?

Samoa on Neowin.net .............will do just fine. :yes: Also include on the check a call contact number in case I have problems cashing the check...

This topic is now closed to further replies.
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • Posts

    • >Improved system sounds when using Windows in dark mode. The story being that bug would be an interesting one.
    • Edifier S3000MKII hi-fi audiophile grade bookshelf speaker is at its lowest price now by Sayan Sen Yesterday we covered a bunch of Dolby Atmos soundbar deals with several ones from Sony, as well as from JBL, Samsung, Polk Audio, and more. You can check them out in this dedicated piece. Those are not audiophile category speakers though as they are built with home theater use in mind. If you are searching for the former then Edifier has its S3000MKII at its lowest price at the moment (purchase link under the specs table down below). This is a two-way bookshelf monitor speaker designed to produce accurate sound. While it may not produce the best high-fidelity audio possible out there, it should still be significantly better than what you will get on soundbars of this price range. As such it will do justice to high-res audio played back through it. The only thing that may feel lacking is sub-bass as Edifier claims the unit can go down to 38 Hz, which should be enough for studio monitor purposes, but not for deep room-shaking rumbling bass. Where this does excel though is in its treble reproduction. With its super-tweeter, it claims to go as high as 40 kHz in the frequency spectrum, which should offer a sense of "air"yness. This is an active speaker which means it packs its own amplfication. It has a top-notch Class D amp that may be able to rival many Class AB designs too in terms of sound reproduction quality. The technical specs of the Edifier S3000MKII are given in the table below: Specification Value RMS Output Power 256W RMS (Treble: 8W × 2, Mid-Low: 120W × 2) Tweeter Driver 107mm × 107mm Planar Magnetic Tweeter Mid-Low Driver 6.5-inch (179mm) Long-Throw Aluminum Diaphragm Driver Frequency Response 38Hz – 40kHz Signal-to-Noise Ratio ≥ 85dB (A) Bluetooth Version Bluetooth 5.0 Bluetooth Codec Qualcomm® aptX™ HD Wireless Speaker Link Proprietary 5.8GHz wireless connection between speakers Supported Hi-Res Audio Hi-Res Audio Certified, up to 24-bit/192kHz Digital Processing XMOS XU216 Digital Signal Processor Audio Inputs Balanced XLR, Optical, Coaxial, USB Type-B, Line In, Bluetooth Input Sensitivity (USB) 400 ± 50mFFs Input Sensitivity (Optical) 400 ± 50mFFs Input Sensitivity (Coaxial) 400 ± 50mFFs Input Sensitivity (Bluetooth) 450 ± 50mFFs Input Sensitivity (Balanced XLR) 1000 ± 50mV Input Sensitivity (Line In) 600 ± 50mV ADC Capability Up to 24-bit/192kHz DSP Capability Up to 24-bit/192kHz DIX Capability Up to 24-bit/216kHz DAC Capability Up to 32-bit/384kHz XMOS Processing Power Up to 2,000 MIPS Edifier S3000MKII Audiophile Active (Powered) Wireless Speakers: $799.99 (Sold by Edifier US, Shipped by Amazon US) If you do not have the kind of budget to spend on the S3000MKII, you can also check out the Edifier R1280Ts which is right now on sale at just $114 (its lowest price in a very long time). Good to know This Amazon deal is U.S. specific, and not available in other regions unless specified. We only use first-party seller links (at the time of article publishing); ensure that you purchase from a first-party seller link only. Check out Today's Deals on Amazon | or our recent tech deals. Become a Prime member (for Students or SNAP) via Neowin Get Prime Access - Prime for half price (for qualifying Medicaid, EBT, SNAP) Subscribe to Prime Video, Audible Plus, Music Unlimited or Kindle Unlimited via Neowin As an Amazon Associate, we earn from qualifying purchases.
    • > The G 7 Pro supports wireless (XBOX Wireless, proprietary dongle, or Bluetooth) If anybody else's brain translates this to 'it works wirelessly on Xbox', according to the linked product page, it does not.
    • Ignoring the fact that this "colony" kicked the empire of King George's arse during those early years... You are confusing the First Industrial Revolution (which was clearly pulled out of some butt-hurt Brit historian's arse after the fact) with the Second Industrial Revolution (aka now called the Technological Revolution, undoubtedly by that same butt-hurt Brit), which transitioned the world from the UK/UPS Empire to the USA as the world's only superpower. https://en.wikipedia.org/wiki/Industrial_Revolution I hope you realize that I am having big fun here.
    • OpenAI announces GPT‑5.6 Sol, its next-generation flagship model beating Claude Mythos 5 by Pradeep Viswanathan Credit: OpenAI OpenAI today announced a limited preview of its new GPT-5.6 model series, which includes the Sol, Terra, and Luna models targeting different price points. GPT-5.6 Sol is the flagship model targeted at demanding reasoning and agentic workloads. GPT-5.6 Terra is positioned as a balanced model for everyday work, featuring performance competitive with GPT-5.5 while being half the cost. GPT-5.6 Luna is the fastest and most affordable model, delivering strong capability at a lower price point. Unlike previous model releases from OpenAI, GPT-5.6 is starting with a limited preview for a small group of trusted partners due to U.S. government restrictions. As expected, OpenAI previewed its plans and the models' capabilities to the U.S. government ahead of launch, and the government asked OpenAI to limit the first wave of access to select partners. OpenAI also mentioned in the official announcement blog post that it does not believe this type of government access process should become the long-term default. OpenAI highlighted that GPT-5.6 Sol comes with a robust safety stack featuring improved protections for higher-risk activity, sensitive cyber requests, and repeated misuse. The company also spent several weeks pressure-testing the system and hardening it against real-world attacks. On the capability side, as expected, GPT-5.6 Sol is OpenAI’s strongest model yet. It delivers better results in agentic performance across coding, biology, and cybersecurity. On the Terminal-Bench 2.1 benchmark, which tests command-line workflows requiring planning, iteration, and tool coordination, GPT-5.6 Sol sets a new record with a score of 91.9%, beating Anthropic's Claude Mythos 5. Additionally, GPT-5.6 introduces a new "max" reasoning effort for even deeper reasoning. The new "ultra" mode uses subagents to accelerate complex work beyond what a single agent can handle. Pricing starts at $5 per million input tokens and $30 per million output tokens for Sol. Terra costs $2.50 for input and $15 for output, while Luna costs $1 for input and $6 for output. GPT-5.6 comes with more predictable prompt caching, including support for explicit cache breakpoints and a 30-minute minimum cache life. Sol will also launch on Cerebras in July at speeds up to 750 tokens per second for select customers. OpenAI plans to make GPT-5.6 Sol, Terra, and Luna broadly available in ChatGPT, Codex, and the API in the coming weeks.
  • Recent Achievements

    • One Year In
      bernmeister earned a badge
      One Year In
    • Week One Done
      Scoobystu earned a badge
      Week One Done
    • Week One Done
      tuben earned a badge
      Week One Done
    • First Post
      OffsetAbs earned a badge
      First Post
    • Reacting Well
      OffsetAbs earned a badge
      Reacting Well
  • Popular Contributors

    1. 1
      +primortal
      441
    2. 2
      +Edouard
      197
    3. 3
      PsYcHoKiLLa
      154
    4. 4
      FloatingFatMan
      71
    5. 5
      Steven P.
      67
  • Tell a friend

    Love Neowin? Tell a friend!